1,264
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study

A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients

, , , ORCID Icon, , , , , & ORCID Icon show all
Pages 447-454 | Received 18 Dec 2019, Accepted 19 Apr 2020, Published online: 13 May 2020

References

  • Harrison R. Structure and function of xanthine oxidoreductase: Where are we now? Free Radic. Biol. Med. 2002;33(6):774–797.
  • Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleos Nucleot Nucleic Acids. 2008;27(6-7):608–619.
  • Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. JASN. 2005;16(3):791–799.
  • Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. JASN. 2008;19(12):2407–2413.
  • Weiner DE, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. JASN. 2008;19(6):1204–1211.
  • Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342–350.
  • Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am. J. Kidney Dis. 2007;50(2):239–247.
  • Denic A, Mathew J, Lerman LO, et al. Single-nephron glomerular filtration rate in healthy adults. N Engl J Med. 2017;376(24):2349–2357.
  • Madero M, Sarnak MJ, Wang X, Greene T, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009;53(5):796–803.
  • Ohno I, Hosoya T, Gomi H, et al. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron. 2001;87(4):333–339.
  • Srivastava A, Kaze AD, McMullan CJ, et al. Uric acid and the risks of kidney failure and death in individuals with CKD. Am J Kidney Dis. 2018;71(3):362–370.
  • De Cosmo S, Viazzi F, Pacilli A, et al.; the AMD-Annals Study Group. Serum uric acid and risk of CKD in type 2 diabetes. CJASN. 2015;10(11):1921–1929.
  • Tsai CW, Chiu HT, Huang HC, et al. Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses. Nephrol Dial Transplant. 2018;33(2):231–241.
  • Park JT, Kim DK, Chang TI, et al. Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant. 2009;24(11):3520–3525.
  • Hsieh YP, Yang Y, Chang CC, et al. U-shaped relationship between uric acid and residual renal function decline in continuous ambulatory peritoneal dialysis patients. Nephrology (Carlton). 2017;22(6):427–435.
  • Chang WX, Xu N, Kumagai T, et al. Uric acid in the follow up determines 30% decline in estimated gfr over 2 years: a propensity score analysis. Kidney Blood Press Res. 2017;42(6):1053–1067.
  • Uchida S, Chang WX, Ota T, et al. Targeting uric acid and the inhibition of progression to end-stage renal disease—a propensity score analysis. PLoS One. 2015;10(12):e0145506.
  • Shu D, Xu F, Su Z, et al. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study. BMC Nephrol. 2017;18(1):11.
  • Bae E, Cho HJ, Shin N, et al. Lower serum uric acid level predicts mortality in dialysis patients. Medicine (Baltimore). 2016;95(24):e3701.
  • Dong J, Han QF, Zhu TY, Ren YP, et al. The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients. PLoS One. 2014;9(1):e82342.
  • Miller BW, Himmele R, Sawin DA, et al. The association of longitudinal serum uric acid and all-cause mortality in incident peritoneal dialysis patients. Blood Purif. 2018;45(1-3):224–229.
  • Perl J, Bargman JM. The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis. 2009;53(6):1068–1081.
  • Termorshuizen F, Korevaar JC, Dekker FW, et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003;41(6):1293–1302.
  • Termorshuizen F, Dekker FW, van Manen JG, et al. Krediet RT; NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis(NECOSAD)-2. J Am Soc Nephrol. 2004;15(4):1061–1070.
  • Kim SB, Yang WS, Min WK, et al. Reduced oxidative stress in hypoalbuminemic CAPD patients. Perit Dial Int. 2000;20(3):290–294.